Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib.
Guan, Jikui, Fransson, Susanne, Siaw, Joachim Tetteh T, Treis, Diana, Van den Eynden, Jimmy, Chand, Damini, Umapathy, Ganesh, Svenberg, Petter, Ruuth, Kristina, Wessman, Sandra, Shamikh, Alia, JacobssLanguage:
english
Journal:
Molecular Case Studies
DOI:
10.1101/mcs.a002550
Date:
June, 2018
File:
PDF, 19.65 MB
english, 2018